If untreated, TTP has a high mortality rate, emphasizing the need for early diagnosis and immediate treatment, typically with plasmapheresis to remove the autoantibodies that inhibit ADAMTS13, the enzyme responsible for preventing excessive clot formation [3]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.